Annovis Bio, Inc. (ANVS) closed the last trading session at $11.10, gaining 9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $34.60 indicates a 211.7% upside potential.The average comprises five short-term price targets ranging from a low of $9 to a high of $72, with a standard deviation of $23.19. While the lowest estimate indicates a decline of 18.9% from the current price leve ...